New Rickettsia spp. are continuously being isolated from ticks around the world, but in most cases their pathogenicity remains to be determined. Some rickettsiae first thought to be nonpathogenic have later been associated with human disease, such as Rickettsia slovaca [1], Rickettsia helvetica [2-4], Rickettsia aeschlimannii [5] and, more recently, the Spanish strain Bar29 (Rickettsia massiliae genogroup), which seems to play a role in the pathogenesis of Mediterranean spotted fever [6] . There are many other rickettsiae that, at least to date, have only been found in ticks, namely (i) genotypes IRS3/IRS4, first isolated in Ixodes ricinus ticks from Slovakia [7] ; (ii) genotypes RpA4 and DnS14, DnS28, DnS79, DnS94 (belonging to the R. massiliae genogroup), which were first isolated, respectively, from Rhipicephalus pumilio and Dermacentor nutalli ticks from the former Soviet Union [8] ; and more recently (iii) the spotted fever group rickettsiae detected in Dermacentor marginatus ticks collected from vegetation in Jaén and La Rioja (Spain), which are closely related to the genotypes DnS14/DnS28 [9] . The pathogenicity of all of these rickettsiae remains uncertain, but since other tick-isolated rickettsiae of previously unknown pathogenicity have been shown to cause human disease, the pathogenic potential of these new rickettsiae deserves specific attention.
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From 1997 to 2002, we collected and identified 3,059 ticks that were attached to people living throughout the region of Castilla y León in northwestern Spain (unpublished data). These ticks belonged to 15 species, although 44.15% of them (1,320 specimens) were in fact I. ricinus, meaning that this species is the most anthropophilic and a serious hazard to human health in this region of Spain. To determine whether the people bitten by I. ricinus were at risk of contracting tick-borne disease, we analyzed all of the ticks by PCR to detect those infected with Rickettsia spp., Borrelia burgdorferi and Anaplasma phagocytophila. Here we report the results of our quest for SFG rickettsiae in I. ricinus ticks, which resulted in the identification, for the first time in Spain, of the pathogenic species R. helvetica as well as the genotypes IRS3 and IRS4.
During the 6-year study period, each tick found on patients who sought medical advice in the hospitals and healthcare centers of Castilla y León was removed and referred to our laboratory. Each tick was first disinfected in 70% alcohol, rinsed in sterile water and dried on sterile filter paper, after which its DNA was extracted in 5% Chelex-100 (BIO-RAD, Hercules, CA, USA). In our search for rickettsiae, we proceeded as described previously [5] : briefly, DNA samples were tested for a fragment of the rickettsial gltA gene, then, in gltA-positive samples, a fragment of the rickettsial ompA gene was amplified, sequenced, and compared for identification. When ompA was not successfully amplified, the gltA amplicon was sequenced and compared. DNA contamination and carry-over of amplified products were prevented by using sterile tools at all times and performing each step of the analysis in separate work areas. Two negative controls (ultra pure water and DNA from laboratory-reared uninfected ticks) were included in each amplification trial. These controls never amplified.
In total, we amplified and sequenced 49 rickettsial amplicons (42 gltA, 7 ompA) from 48 I. ricinus ticks; in one tick, both amplicons were obtained. Eight gltA amplicons had 100% sequence identity with the gltA of R. helvetica (GenBank, U59423). The remaining 34 gltA amplicons had the following identities: 24 were identical to the gltA of IRS3 (GenBank, AF140706); four were identical to the gltA of IRS4 (GenBank, AF141906); one was identical and three were >99% identical to the gltA of R. massiliae/Bar29 (GenBank, U59719/U59720); one was >99% identical to the gltA of R. aeschlimannii (GenBank, U59722) [see ref . 5] , and one was >99% identical to the gltA of Rickettsia RpA4/DnS14 (GenBank, AF120029/ AF120028). Of the seven ompA amplicons sequenced, two shared >99% identity with the ompA of R. aeschlimannii (GenBank, U43800) [see ref . 3] ; one was identical to the ompA of IRS3 (GenBank, AF141909); one was identical and three were >99% identical to the ompA of IRS4 (GenBank, AF141911). The two amplicons (gltA and ompA) sequenced from the same tick were both identified as genotype IRS4.
Thus, we found 48 rickettsiae-positive I. ricinus specimens among the 1,320 analyzed (infection rate, 3.6%). Of these infected I. ricinus, 15 (31.2%) carried pathogenic rickettsiae: eight (16.7%) R. helvetica, four (8.3%) R. massiliae/Bar29 and three (6.3%) R. aeschlimannii. The remaining 33 (68.8%) specimens carried rickettsiae of uncertain pathogenicity: 32 (66.7%) were genotypes IRS3 and IRS4 and only one (2.1%) was genotype RpA4 or DnS14. We did not find any ticks infected with more than one Rickettsia sp., but we did find B. burgdorferi in one I. ricinus tick infected with R. helvetica, in five ticks infected with IRS3, and in one tick infected with R. massiliae/ Bar29. We also found A. phagocytophila in another IRS4-infected tick.
The 48 rickettsiae-positive ticks were removed within the first 12 post-attachment hours (i.e., before they could have ingested any blood), thus indicating they were infected with the bacteria prior to the human attachment. The people bitten by these specimens were asymptomatic at the time of tick removal and they did not subsequently develop any symptoms.
Rickettsia helvetica is widely distributed in Europe [4] ; it is also present in Japan [3, 10, 11] , and there is serological evidence of its presence in Thailand [4] . However, it has never been detected in Spain. The genotypes IRS3 and IRS4 have been found in I. ricinus from Slovakia [7] , Italy [12] , and some countries of southeastern Europe [13] , but they have not been previously reported in Spain. Thus, this report is the first to document the presence of R. helvetica and genotypes IRS3 and IRS4 in this country. These observations expand the known geographic distribution of these three bacteria and seem to support their specificity to I. ricinus, since they were not found in any other tick species. Our observations also apparently enlarge the range of potential tick vectors of R. massiliae/Bar29 (to date only associated with the genus Rhipicephalus) and that of the genotypes RpA4 and DnS14 (to date associated with the genera Rhipicephalus and Dermacentor).
In conclusion, our results indicate that people living in Castilla y León (Spain) are frequently bitten by I. ricinus and that, once bitten, these individuals have a 1.12% risk of becoming infected with pathogenic rickettsiae (i.e., R. helvetica, R. aeschlimannii and Bar29) as well as a 2.48% risk of becoming infected with rickettsiae of unknown pathogenicity. Furthermore, since several of the I. ricinus we studied were coinfected with more than one tick-borne pathogen, the simultaneous transmission of these pathogens to people via a single I. ricinus bite cannot be excluded.
